Patent classifications
A61K2236/37
Cannabinoids infused coffee beans and raw nuts
The present disclosure is directed to whole spectrum cannabinoids infused coffee beans or raw nuts and methods of producing the cannabinoids infused coffee beans or raw nuts. The coffee beans or raw nuts are infused in an overall two-step process, in which cannabinoids from a Cannabis species are first infused into coconut oil, which in turn is used to infuse coffee beans or raw nuts with cannabinoids to generate the cannabinoids infused coffee beans or raw nuts.
COMPOSITON FOR PREVENTING OR TREATING OSTEOPOROSIS
A composition for preventing or treating osteoporosis, contains a Gentiana scabra extract and a Sambucus williamsii extract. The composition for preventing or treating osteoporosis is capable of increasing bone formation and inhibiting bone resorption. In addition, the composition increases bioaffinity and has no side effects by containing a Gentiana scabra extract and a Sambucus williamsii extract, which are natural products, thereby stably exhibiting an effect of preventing or treating osteoporosis.
METHOD FOR IMPROVING SARCOPENIA BY USING PHELLINUS LINTEUS
The invention provides a method for improving sarcopenia of a subject in need thereof by using Phellinus linteus, in which the method includes administering an effective dose of composition to the subject, and the composition includes Phellinus linteus (NITE BP-03321 and BCRC 930210) as an effective substance. By using the aforementioned composition including an extract of a fermented product of the Phellinus linteus and/or its derivative, diameters of myotubes, amounts of muscles and muscle muscular endurance can be maintained, thereby improving sarcopenia.
BOTANICAL EXTRACTION
Methods for extracting compounds of interest from a botanical material are disclosed herein. The methods include identifying optimal natural deep eutectic solvents (NaDESs), mixing the identified NaDESs with a botanical material, and isolating compounds of interest from the mixture. Also described are compositions that include the isolated compounds of interest with NaDESs.
Process for production of red ginseng hydrolysis concentrate having enriched specific component
A method for production of red ginseng hydrolysis concentrate according to an embodiment of the present disclosure includes carrying out an enzyme reaction of red ginseng concentrate by adding an enzyme solution followed by addition of alcohol to prepare a mixture solution of red ginseng and alcohol, and centrifuging the prepared mixture solution of red ginseng and alcohol followed by concentration under reduced pressure of a supernatant separated by the centrifuge, and a red ginseng hydrolysis concentrate produced by the aforementioned process.
Aloe Based Compositions Comprising Polysaccharides and Polyphenols for Regulation of Homeostasis of Immunity
Compositions used and methods are disclosed for regulation of immunity homeostasis including a combination of an Aloe extract enriched for one or more polysaccharides; a Poria extract enriched for one or more polysaccharides; and a Rosemary extract enriched for one or more polyphenolic compounds. Compositions for maintenance of immunity homeostasis by regulating HMGB1, comprising a combination of one or more polysaccharides and one or more polyphenolic compounds are disclosed. Methods for treating, managing, promoting regulation of immunity homeostasis in a mammal are disclosed that include administering an effective amount of a composition from 0.01 mg/kg to 500 mg/kg body weight of the mammal.
ANTIBACTERIAL AND ANTIVIRUS COMPOSITION COMPRISING Extract of CANNABIS SATIVA L.
The present disclosure relates to an antibacterial and antiviral composition containing an extract of Cannabis sativa L. as an active ingredient. More specifically, the present disclosure provides an antibacterial and antiviral composition which contains an extract of the natural product Cannabis sativa L., and thus may exhibit antibacterial and antiviral activities, and when taken or administered, has no side effects and does not cause bacterial or viral resistance.
METHODS AND SYSTEMS FOR THE SELECTIVE EXTRACTION OF PHYTOCHEMICALS
The present application relates to the extraction of phytochemicals, more specifically to methods and systems for the selective extraction of phytochemicals from biomass. A method may comprises placing the biomass into a thermal chamber, the thermal chamber being connected with an eductor through a suction connection, and a discharge port of the eductor being connected to a concentrate tank; generating a vacuum in the thermal chamber by circulating a motive fluid through the eductor; heating the biomass to volatilize one or more phytochemicals; condensing the one or more volatilized phytochemicals by contacting the volatized phytochemicals with the motive fluid; and collecting the one or more condensed phytochemicals into the concentrate tank.
Composition for Neuroprotection, Containing Plant Extract or Fraction as Active Ingredient
A Maclura pubescens extract or fraction or a Prunus cerasoides extract or fraction having neuroglobin (Ngb) activation and neuroprotective effects and, on the basis thereof, a neuroprotective composition containing, as an active ingredient, a Maclura pubescens extract or fraction or a Prunus cerasoides extract or fraction. The neuroprotective composition can be used, through the activation of neuroglobin (Ngb), as a pharmaceutical composition or a food composition for treatment, alleviation and prevention of a stroke, a cerebral infarction, thrombosis, cerebral degenerative disease, vascular dementia, memory loss, short-term memory impairment, a concentration disorder, anxiety, nervousness and the like, and for brain damage protection, brain function improvement and cranial nerve cell protection.
EXTRACT OF GINKGO BILOBA LEAVES AND PREPARATION METHOD THEREFOR
The present disclosure provides a Ginkgo biloba ketone ester bulk drug. The present disclosure further provides a method for preparing Ginkgo biloba ketone ester bulk drug and use thereof. The present disclosure provides a Ginkgo biloba ketone ester and a preparation method thereof. Through optimized preparation operations and conditions, high-quality Ginkgo biloba ketone ester bulk drug can be obtained. Compared with the Ginkgo biloba ketone ester prepared by traditional methods, the Ginkgo biloba ketone ester of the present disclosure has stable quality, low unqualified rate, and good consistency of different batches of bulk drugs.